Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi

IMPORTANCE: Left ventricular (LV) thrombi can arise in patients with ischemic and nonischemic cardiomyopathies. Anticoagulation is thought to reduce the risk of stroke or systemic embolism (SSE), but there are no high-quality data on the effectiveness of direct oral anticoagulants (DOACs) for this i...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA Cardiol
Main Authors: Robinson, Austin A., Trankle, Cory R., Eubanks, Grayson, Schumann, Christopher, Thompson, Paul, Wallace, Ryan L., Gottiparthi, Shouri, Ruth, Benjamin, Kramer, Christopher M., Salerno, Michael, Bilchick, Kenneth C., Deen, Cody, Kontos, Michael C., Dent, John
Formato: Artigo
Idioma:Inglês
Publicado: American Medical Association 2020
Assuntos:
Original Investigation
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7177639/
https://ncbi.nlm.nih.gov/pubmed/32320043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2020.0652
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares